RTI Biologics Donates Matrix HD™ To Treat Young Child With Rare Genetic Skin Condition
RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD™, to treat an eight-year old patient with a rare skin disease called recessive dystrophic epidermolysis bullosa (EB)…
Also tagged Biologics Inc, Dermis, Epidermolysis Bullosa, Hd, Implants, Matrix, Nasdaq, Rare Disease, Rare Skin Disease, Rti, Rtix, Skin Condition
